Professional Documents
Culture Documents
CBC (Complete Blood Count)
CBC (Complete Blood Count)
Blood
NORMAL VALUES:
A- RBCs:
Male 4.5 - 6.5 million cells/mm3
Female 3.8 - 5.8 million cells/ mm3
Male 40 –50 %
Female 36 – 44 %
C- Haemoglobin:-
Male 13 – 18 gm/dl
Female 12 – 16 gm/dl
Hb % may be used
Colour index:-
Hb%\RBCs % = 1
> 1 = hyperchromic (wrong term)
< 1 = hypochromic.
Of no value in recent medicine
56
CLINICAL PATHOLOGY
MCV: 80 - 95 femtoliter
D- RBCs indices MCH: 27 - 31 pg/cell
MCHC: 32 - 36 gm/dl
1- Mean corpuscular volume (MCV):-
measures the mean or average size of individual red blood cells
57
CLINICAL PATHOLOGY
The MCH and the MCHC are used to assess whether red blood cells are
normochromic, hypochromic, or hyperchromic .
58
CLINICAL PATHOLOGY
Scheme of diagnosis
1st step RBCs (Hb)
Decreased
Increased
increased Decreased
Acute L Chronic L Normocytic normochromic Microcytic hypochromic Macrocytic
Increased reticulocytes Fe deficiency: Decreased Fe Level Megaloblastic
Acute bleeding + Marked eosinophilia:- Ankylostoma anaemia
Haemolytic anaemia Chronic blood loss
59
CLINICAL PATHOLOGY
Increased
normal Decreased
Acute Chronic
Mainly PNL Abnormal monocytes (blast cells > 30 % (blast cells < 30 %
) )
60
CLINICAL PATHOLOGY
Pancytopenia
Reticulocytes
Increased Decreased
BLOOD FILM:-
Shape:- biconcave
Abnormal shapes:-
Poikilocytosis :- Variable
Sherocytes:- hereditary sherocytosis – autoimmune haemolytic
Sickle:- sickle cell anaemia
Elliptical:- membrane defct
Stomatocytes:- membrane defect
Target:- thalassemia – LCF –O.J. – after splenectomy
Hinz bodies: pyrovate kinase deficiency
Papenhiemer bodies: sidroblastic
61
CLINICAL PATHOLOGY
62
CLINICAL PATHOLOGY
63
CLINICAL PATHOLOGY
Urine analysis
Colour & aspect : clear yellow Bile salts : Nill Crystals : Nill
Urine pH 5-7
High acidity with Ca. oxalate & uric acid but alkaline with
phosphates
Urin may react alkaline by standing
Glucose
The renal threshold of glucose is approximately 180 mg/dl.
Q: Causes of Glucosuria?
64
CLINICAL PATHOLOGY
Specific Gravity
The ability of the kidney to concentrate urine.
Increase specific gravity are:
A) Increased excretion of metabolites:- DM and addisone disease
B) Decreased plasm blood flow:- HF
C) loss of body water:- dehydration, diarrhea and vomiting.
Decreased specific gravity:- Renal failure and diabetes insipidus
NB. Specific gravity will normally vary with the amount of fluid intake and the
time of dayat which the specimen was collected.
65
CLINICAL PATHOLOGY
Crystals
Common crystals seen even in healthy patients include:-
Calcium oxalate, triple phosphate crystals and amorphous
phosphates.
Cystine crystals neonates with congenital cystinuria or severe liver
disease
Tyrosine crystals with congenital tyrosinosis or marked liver
impairment
Leucine crystals in patients with severe liver disease
Ketones
Acetone, and beta-hydroxybutyric acid, are found in the urine
when the body is metabolizing large amounts of fatty acids
(inadequate carbohydrate utilization) as seen in diabetes, fasting,
alcoholic and starvation
66
CLINICAL PATHOLOGY
A ) Oliguria B ) Polyuria
High specific gravity Fixed 1010 High specific gravity Low specific gravity Fixed 1010
A ) Functional ( ARF High glucose : D.I CRF
dehydration ) DM
Normal RBCs .
B ) Glomerulonephritis : Protenurea in Water depriviation test On top of
RBCs & smoky urine Diabetic nephropathy GN : RBCs casts
PN : Pus cells
67
CLINICAL PATHOLOGY
Report No 1 Report No 2
1 Volume 1200 cc\day 1 Volume 2500
2 Aspect Clear 2 Aspect Clrar
3 Sp. G. 1018 3 Sp. G. 1140
4 Sugar Nil. 4 Sugar ++++
5 Albumin Nil. 5 Albumin +
6 RBCs 0-1 HPF 6 RBCs 0-1 HPF
7 Pus cells 4 HPF 7 Pus cells 4 HPF
8 Casts Hyaline 8 Casts Hyaline
9 Others Nil 9 Others Nil
10 Reaction Acidic 10 Reaction Acidic
Report No 3 Report No 4
1 Volume 2300 cc\day 1 Volume 500
2 Aspect Watery 2 Aspect Smoky
3 Sp. G. 1010 3 Sp. G. 1032
4 Sugar Nil. 4 Sugar +
5 Albumin + 5 Albumin +
6 RBCs Nil. 6 RBCs 20 HPF
7 Pus cells 1 \ HPF 7 Pus cells 2 HPF
8 Casts Hy. & granular 8 Casts Red
9 Others Nil 9 Others Nil
10 Reaction - 10 Reaction
68
CLINICAL PATHOLOGY
Report No 5 Report No 6
1 Volume 1000 cc\day 1 Volume 1500
2 Aspect Turbid 2 Aspect Brown
3 Sp. G. 1024 3 Sp. G. 1017
4 Sugar + 4 Sugar +
5 Albumin + 5 Albumin +
6 RBCs Nil. 6 RBCs 2 \ HPF
7 Pus cells 50 \ HPF 7 Pus cells 2 \ HPF
8 Casts Hy. & WBCs 8 Casts Hyaline
9 Others Nil 9 Others Bile salts
10 Reaction - 10 Reaction -
Report No 7 Report No 8
1 Volume 2500 cc\day 1 Volume 500
2 Aspect Watery 2 Aspect Clear
3 Sp. G. 1040 3 Sp. G. 1095
4 Sugar ++++ 4 Sugar Nil.
5 Albumin +++ 5 Albumin Nil.
6 RBCs Nil. 6 RBCs 1 \ HPF
7 Pus cells 1 \ HPF 7 Pus cells 5 \ HPF
8 Casts Lipoid & granular 8 Casts Hyalin
9 Others Nil 9 Others Nil.
10 Reaction - 10 Reaction -
Report No 9 Report No 10
1 Volume 600 cc\day 1 Volume 3500
2 Aspect Smoky 2 Aspect Watery
3 Sp. G. 1010 3 Sp. G. 1010
4 Sugar Nil. 4 Sugar Nil.
5 Albumin Nil. 5 Albumin +
6 RBCs 30 \ HPF 6 RBCs 2 \ HPF
7 Pus cells 1 \ HPF 7 Pus cells 40 \ HPF
8 Casts Hyaline, granular, 8 Casts Hyaline,
RBCs granular, WBCs
9 Others Nil 9 Others Nil
10 Reaction - 10 Reaction
69
CLINICAL PATHOLOGY
Report No 11 Report No 12
1 Volume 4500 cc\day 1 Volume 1100
2 Aspect Clear 2 Aspect Reddish
3 Sp. G. 1004 3 Sp. G. 1020
4 Sugar + 4 Sugar +
5 Albumin + 5 Albumin +
6 RBCs Nil. 6 RBCs 140 \ HPF
7 Pus cells 3 \ HPF 7 Pus cells 2 \ HPF
8 Casts Hy. 8 Casts Hyaline
9 Others Nil 9 Others -
10 Reaction - 10 Reaction -
Chemical Chemical
Glucose Nill. Glucose Nill.
Protein ++ Protein Nill.
Bile salt Nill. Bile salt Nill.
Bile pig. Bile pig.
a) bilirubin Nill a) bilirubin Nill
b) urobilinogen Trace b) urobilinogen Trace
Microscopic Microscopic
Epithelial cells ++ Epithelial cells Nill.
RBCs 3 HPF RBCs 3 \ HPF
WBCs 100 HPF WBCs 2 \ HPF
Crystale Nill. Crystale Nill.
Casts Hyaline Casts Hyaline
70
CLINICAL PATHOLOGY
Chemical Chemical
Glucose Nill. Glucose Nill.
Protein Nill. Protein ++++
Bile salt +++ Bile salt Nill.
Bile pig. Bile pig.
a) bilirubin ++ a) bilirubin Nill
b) urobilinogen Nill. b) urobilinogen Trace
Microscopic Microscopic
Epithelial cells Nill. Epithelial Nill.
cells
RBCs 3 \ HPF
RBCs 3 \ HPF
WBCs 2 \ HPF
WBCs 2 \ HPF
Crystale Nill.
Crystale Nill.
Casts Hyaline
Casts Hyaline & lipoid
71
CLINICAL PATHOLOGY
Serum urea:- 20 – 40 mg %
Serum creatinine:- < 1mg %
Uric acid :- 2 – 7 mg %
Electrolytes:-
Report No.1
1 Serum urea 250 mg % (20 – 40 mg %)
2 Serum creatinine 10.5 mg% (0.2 – 1.2mg %)
3 Uric acid 9 mg% (2 – 7 mg %)
4 Sodium 128 mEq/L (135 - 145
mEq/L)
5 Potassium 6 mEq/L (3.5 - 5.2 mEq/L)
6 Chloride (98 – 106 mEq/L)
7 Calcium 7.1 mg % (8.4 - 10.5
mg/dL)
8 Phosphate 8 mg % (2.5 - 5.0 mg/dL)
9 Bicarbonate (22 - 29 mEq/L)
10 BUN (7 – 18 mg/dL)
S glucose 200 mg %
72
CLINICAL PATHOLOGY
Report No.2
1 Serum urea 140 mg % (20 – 40 mg %)
2 Serum creatinine 3.1 mg% (0.2 – 1.2mg %)
3 Uric acid (2 – 7 mg %)
4 Sodium 139 mEq/L (135 - 145
mEq/L)
5 Potassium 5.8 mEq/L (3.5 - 5.2 mEq/L)
6 Cholesterol 350 mg % (50 – 250 mg %)
7 Total protein 6 gm % (6.5 – 8.5 gm %)
8 Albumin 2.3 gm % (3.5 – 5.5 gm %)
Report No.3
1 Serum urea 50 mg % (20 – 40 mg %)
2 Serum creatinine 1.2 mg% (0.2 – 1.2mg %)
3 Sodium 139 mEq/L (135 - 145
mEq/L)
4 Potassium 5.0 mEq/L (3.5 - 5.2 mEq/L)
5 Cholesterol 230 mg % (50 – 250 mg %)
6 Total protein 6 gm % (6.5 – 8.5 gm %)
7 Albumin 4.3 gm % (3.5 – 5.5 gm %)
73
CLINICAL PATHOLOGY
CSF
Normal results :
Physical Composition
Colour : colourless Cl : 720 – 750 mg / dl
Cells : 0 – 5 / HPF
74
CLINICAL PATHOLOGY
75
CLINICAL PATHOLOGY
Stool analysis
2nd step
Steatorrhea Look at
76
CLINICAL PATHOLOGY
77
CLINICAL PATHOLOGY
78
CLINICAL PATHOLOGY
I. Synthetic function
1. Plasma proteins:
- Total protein: 6-8 gm/dl
- Albumin: 3.5-5.5 gm/dl
- Globulin: 1.7-2.7 gm/dl
- AIG ratio: 2/1
-
Albumin is synthesized by liver only, and it has a long half life so
affected in chronic liver disease and AIG ratio may be reduced (1/2)
2. Prothrombin: P.T. = 12-14 sec.
Only synthesized by liver depending on vit.k &
has a short half life so affected in acute or chronic
liver disease
I.N.R = international normalization ratio
= patient prothrombin T./ normal prothrombin = 0.8-1.2
- Used in monitoring patient on oral anticoagulant
II. Excretory
- Total Bilirubin < 1mg/dl ( in all types of jaundice)
- Direct Bilirubin < 0.2 mg/dl ( in obstructive
jaundice)
- Indirect Bilirubin < 0.8 mg/dl ( in hemolytic)
N.B.: Both are elevated in hepato cellular jaundice
79
CLINICAL PATHOLOGY
80
CLINICAL PATHOLOGY
Biphasic
High direct High indirect
( high direct &
( Cholebilirubin ) ( Haemobilirubin )
indirect )
Look at
Look at
Liver enzymes ( normal )
Alk ph . > 30 K.A.U
Look at A / G ratio
81
CLINICAL PATHOLOGY
82
CLINICAL PATHOLOGY
Report No. 5
1 Protein 7 gm/dL (N. 6.6 - 8.6) gm/dL
2 Albumin 3.8 gm/dL (N. 3.5 – 5.5) gm/dL
3 Total bilirubin 3.2 mg/dL (N. 0.1 – 1.0) mg/dL
4 Dir. Bilirubin 1.2 mg/dL (N. 0.0 – 0.25) mg/dL
5 SGOT (AST) 1250 U/L (N. 0 – 32) U\L
6 SGPT (ALT) 1550 U/L (N. 0 – 31) U\L
7 Alk. Phosphatase 390 U \L (N. 79 – 240) U\L
Report No. 6
1 Protein 7.4 gm/dL (N. 6.6 - 8.6) gm/dL
2 Albumin 2.9 gm/dL (N. 3.5 – 5.5) gm/dL
3 A\G 0.6 (N. 1.1 – 2.5)
4 Total bilirubin 0.88 mg/dL (N. 0.1 – 1.0) mg/dL
5 Dir. Bilirubin 0.35 mg/dL (N. 0.0 – 0.25) mg/dL
6 SGOT (AST) 95 U/L (N. 0 – 32) U\L
7 SGPT (ALT) 80 U/L (N. 0 – 31) U\L
Alk. Phosphatase 287 U\L (N. 79 – 240) U\L
83
CLINICAL PATHOLOGY
84
CLINICAL PATHOLOGY
85
CLINICAL PATHOLOGY
Indications:
For diagnosis of Diabetes Mellitus (DM)
To differentiate between patients with DM and Impaired Glucose
Tolerance (IGT)
Patient preparation:
Allow at least three days of unrestricted diet (carbohydrate
intake > 200 g/day) prior to testing.
If the patient is febrile or acutely ill, the test should be
postponed until clinical improvement.
Allow at least six weeks after myocardial infarction or major
surgery before testing.
Procedure:
1. Fast the patient overnight 6-10 hours (water allowed).
2. Patient should rest for at least 30 mins prior to testing.
3. No food, drink or cigarette smoking is allowed until the test is
completed.
4. Take blood and urine samples for "fasting" glucose level
5. The patient is given 75 g of glucose followed by a further 100
mls water, consumed over a 5 min period.
6. Serial samples are taken every 30 minutes after the glucose
load
7. Between samples, the patient should ideally remain seated.
Normal value
WHO criteria for Venous Plasma measurements. For non pregnant
individuals these are:
86
CLINICAL PATHOLOGY
Diagnosis of D.M.
1. F.B.G. ≥ 126 mg/dl
2. 2nd hr p.p. B.G ≥ 200 mg/dl
3. 2nd hr P.P. B.G = 140 – 200 mg/dl
= Impaired G.T.T.
Glucosuria without D.M look at 1st hr P.P. B.G
Keton in urine:-
1- in starvation & alcoholism
2- in severe DM
Report No. 1 Report No. 2
1 Urine gluc. + ve in all samples 1 Urine gluc. + ve in 1st
sample
2 Fasting 300 mg % 2 Fasting 175 mg %
3 1st hour 350 mg % 3 1st hour 195 mg %
4 2nd hour 220 mg % 4 2nd hour 160 mg %
Report No. 5
1 Urine gluc. - ve in all
samples
2 Fasting 90 mg %
3 1st hour 170 mg %
nd
4 2 hour 110 mg %
Serological tests
88
CLINICAL PATHOLOGY
89
CLINICAL PATHOLOGY
90
CLINICAL PATHOLOGY
Normal values:-
T3 1.3 – 5.0 pg/dL
T4 0.8 - 2.0 pg/dL
TSH 0.3 - 5.0 IU/mL
Level of T3 & T4
Report No. 3
T3 6.7 pg% (N.1.3 -5.0)
T4 4.9 ng% (N. 0.8 – 2.0)
TSH < 0.01 IU \ml (N.0.3 – 5.0)
91
CLINICAL PATHOLOGY
5- Troponin
- Peaks in 10-24 hours, begins to fall off after 1-2 weeks.
Tropinin T and I, are specific to myocardium T and I, are specific to
myocardium
Tropinin T and I: < 0.0 - 0.10 µg/mL.
92